tbuckley/cabot-search huggingface dataset:
20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
Authors: Heidi Taipale, Antti Tanskanen, Juha Mehtälä, Pia Vattulainen, Christoph U. Correll, Jari Tiihonen
Journal: World Psychiatry (2020)

Antipsychotics are effective in preventing relapses of schizophrenia, but it is generally believed that their long‐term use is harmful for patients’ physical well‐being. However, there are no long‐term studies which have verified this view. This nationwide, register‐based cohort study aimed to assess the risk of hospitalization due to physical health problems, as a marker for severe physical morbidity, and the risk of all‐cause mortality, as well as of cardiovascular and suicidal death, associated with antipsychotic use in all patients treated for schizophrenia in inpatient care between 1972 and 2014 in Finland (N=62,250), with up to 20 years of follow‐up (median: 14.1 years). The use of antipsychotic drugs (i.e., use of any antipsychotic compared with non‐use) and the use of specific antipsychotics were investigated, and outcomes were somatic and cardiovascular hospitalization, and all‐cause, cardiovascular and suicide death. Hospitalization‐based outcomes were analyzed by a within‐individual design to eliminate selection bias, comparing use and non‐use periods in the same individual by stratified Cox model. Mortality outcomes were assessed by traditional between‐individual Cox multivariate models. The adjusted hazard ratios (aHRs) for any somatic hospitalization and cardiovascular hospitalization were 1.00 (95% CI: 0.98‐1.03) and 1.00 (95% CI: 0.92‐1.07) during use of any antipsychotic compared to non‐exposure periods within the same individual. The aHRs were 0.48 (95% CI: 0.46‐0.51) for all‐cause mortality, 0.62 (95% CI: 0.57‐0.67) for cardiovascular mortality, and 0.52 (95% CI: 0.43‐0.62) for suicide mortality during use vs. non‐use of any antipsychotic. The most beneficial mortality outcome was associated with use of clozapine in terms of all‐cause (aHR=0.39, 95% CI: 0.36‐0.43), cardiovascular (aHR=0.55, 95% CI: 0.47‐0.64) and suicide mortality (aHR=0.21, 95% CI: 0.15‐0.29). The cumulative mortality rates during maximum follow‐up of 20 years were 46.2% for no antipsychotic use, 25.7% for any antipsychotic use, and 15.6% for clozapine use. These data suggest that long‐term antipsychotic use does not increase severe physical morbidity leading to hospitalization, and is associated with substantially decreased mortality, especially among patients treated with clozapine.
Phase II Study of Pemetrexed in Elderly (≥75) Non-Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group Trial 0901
Authors: Y.H. Kim, M. Hirabayashi, S. Kosaka, J. Nikaidoh, Y. Yamamoto, M. Shimada, T. Toyazaki, H. Nagai, M. Mishima
Journal: Annals of Oncology (2012)
P-0303 Safety and Tolerability data from A Phase II Study of Auy922 Compared with Chemotherapy in Patients with Advanced Gastric Cancer
Authors: Kun-Huei Yeh, Jen-Shi Chen, Alberto Sobrero, Nimit Singhal, Sara De Dosso, Yoon-Koo Kang, Seok Yun Kang, Han-Chong Toh, Jean-Pierre Delord, Mikhail Akimov, Lisa Nardi, Scott Pain, Zev Wainberg
Journal: Annals of Oncology (2012)
Influenza increases invasive meningococcal disease risk in temperate countries
Authors: A. Salomon, I. Berry, A.R. Tuite, S. Drews, T. Hatchette, F. Jamieson, C. Johnson, J. Kwong, B. Lina, J. Lojo, A. Mosnier, V. Ng, P. Vanhems, D.N. Fisman
Journal: Clinical Microbiology and Infection (2020)
Adverse Events in Elderly Patients on Adjuvant Therapy With UFT/LV OR S-1 For Stage III Colon Cancer: ACTS-CC Trial [TRICC0706]
Authors: M. Ishiguro, H. Uetake, T. Ishikawa, Y. Kusunoki, F. Kinoshita, N. Kashiwagi, Y. Nagata, Y. Matsubara, K. Sugihara
Journal: Annals of Oncology (2012)
P-0241 A Comparison of Xeliri Plus Bevacizumab with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer
Authors: Bilici Ahmet, Kazim Uygun, Serap Kaya, Bala Basak Oven Ustaalioglu, Ramazan Yildiz, Suleyman Temiz, Mesut Seker, Gorkem Aksu, Devrim Cabuk, Mahmut Gumus
Journal: Annals of Oncology (2012)
Clinical characteristics and cytokine biomarkers in patients with chronic graft‐vs‐host disease persisting seven or more years after diagnosis
Authors: Sencer Goklemez, Annie P. Im, Liang Cao, Filip Pirsl, Seth M. Steinberg, Lauren M. Curtis, Sandra A. Mitchell, Edward W. Cowen, Judy Baruffaldi, Jeremy Rose, Jacqueline Mays, Alen Ostojic, Noa G. Holtzman, Frances T. Hakim, Steven Z. Pavletic
Journal: American Journal of Hematology (2020)

Chronic graft-versus-host disease (cGVHD) is the leading late complication after allogeneic hematopoietic stem cell transplantation (HSCT). Many patients receive multiple lines of systemic therapy until cGVHD resolves, but about 15% remain on systemic treatment for more than 7 years after cGVHD diagnosis. This study describes the clinical and biological factors of patients who present with cGVHD persisting for ≥7 years (persistent cGVHD). Patients with persistent cGVHD (n = 38) and those with cGVHD for <1 year (early cGVHD) (n = 83) were enrolled in a prospective cross-sectional natural history study. Patients in the persistent cGVHD group were a median of 10.2 years from cGVHD diagnosis (range 7-27 years). Fifty-eight percent of persistent cGVHD patients (22/38) were receiving systemic immunosuppression, compared to 88% (73/83) in the early cGVHD group. In multivariable analysis, bone marrow (BM) stem cell source, presence of ENA autoantibodies, higher NIH lung score, higher platelet counts, and higher IgA levels were significantly associated with persistent cGVHD. A high sensitivity panel of serum biomarkers including seven cytokines diagnostic for cGVHD was analyzed and showed significantly lower levels of BAFF and CXCL10 in patients with persistent cGVHD. In conclusion, standardly accepted clinical measures of disease severity may not accurately reflect disease activity in patients with persistent cGVHD. However, many patients with persistent cGVHD are still receiving systemic immunosuppression despite lacking evidence of disease activity. Development of reliable clinical biomarkers of cGVHD activity may help guide future systemic treatments.
Ancient DNA Evidence from China Reveals the Expansion of Pacific Dogs
Authors: Ming Zhang, Guoping Sun, Lele Ren, Haibing Yuan, Guanghui Dong, Lizhao Zhang, Feng Liu, Peng Cao, Albert Min-Shan Ko, Melinda A Yang, Songmei Hu, Guo-Dong Wang, Qiaomei Fu
Journal: Molecular Biology and Evolution (2020)

Abstract The ancestral homeland of Australian dingoes and Pacific dogs is proposed to be in South China. However, the location and timing of their dispersal and relationship to dog domestication is unclear. Here, we sequenced 7,000- to 2,000-year-old complete mitochondrial DNA (mtDNA) genomes of 27 ancient canids (one gray wolf and 26 domestic dogs) from the Yellow River and Yangtze River basins (YYRB). These are the first complete ancient mtDNA of Chinese dogs from the cradle of early Chinese civilization. We found that most ancient dogs (18/26) belong to the haplogroup A1b lineage that is found in high frequency in present-day Australian dingoes and precolonial Pacific Island dogs but low frequency in present-day China. Particularly, a 7,000-year-old dog from the Tianluoshan site in Zhejiang province possesses a haplotype basal to the entire haplogroup A1b lineage. We propose that A1b lineage dogs were once widely distributed in the YYRB area. Following their dispersal to South China, and then into Southeast Asia, New Guinea and remote Oceania, they were largely replaced by dogs belonging to other lineages in the last 2,000 years in present-day China, especially North China.
Does the Compliance to Adjuvant Chemotherapy Depend on Neoadjuvant Radiation Therapy Modality?
Authors: K. Chan, T. Vuong, P. Kavan, T. Niazi, C. Holcroft, E. Ferland, J. Sturgeon, D. Melnychuk, T. Alcindor, G. Batist
Journal: Annals of Oncology (2012)
Cerebellar oscillations driven by synaptic pruning deficits of cerebellar climbing fibers contribute to tremor pathophysiology
Authors: Ming-Kai Pan, Yong-Shi Li, Shi-Bing Wong, Chun-Lun Ni, Yi-Mei Wang, Wen-Chuan Liu, Liang-Yin Lu, Jye-Chang Lee, Etty P. Cortes, Jean-Paul G. Vonsattel, Qian Sun, Elan D. Louis, Phyllis L. Faust, Sheng-Han Kuo
Journal: Science Translational Medicine (2020)

Essential tremor (ET) is one of the most common movement disorders and the prototypical disorder for abnormal rhythmic movements. However, the pathophysiology of tremor generation in ET remains unclear. Here, we used autoptic cerebral tissue from patients with ET, clinical data, and mouse models to report that synaptic pruning deficits of climbing fiber (CF)-to-Purkinje cell (PC) synapses, which are related to glutamate receptor delta 2 (GluRδ2) protein insufficiency, cause excessive cerebellar oscillations and might be responsible for tremor. The CF-PC synaptic pruning deficits were correlated with the reduction in GluRδ2 expression in the postmortem ET cerebellum. Mice with GluRδ2 insufficiency and CF-PC synaptic pruning deficits develop ET-like tremor that can be suppressed with viral rescue of GluRδ2 protein. Step-by-step optogenetic or pharmacological inhibition of neuronal firing, axonal activity, or synaptic vesicle release confirmed that the activity of the excessive CF-to-PC synapses is required for tremor generation. In vivo electrophysiology in mice showed that excessive cerebellar oscillatory activity is CF dependent and necessary for tremor and optogenetic-driven PC synchronization was sufficient to generate tremor in wild-type animals. Human validation by cerebellar electroencephalography confirmed that excessive cerebellar oscillations also exist in patients with ET. Our findings identify a pathophysiologic contribution to tremor at molecular (GluRδ2), structural (CF-to-PC synapses), physiological (cerebellar oscillations), and behavioral levels (kinetic tremor) that might have clinical applications for treating ET.
Predictive and Prognostic Role of Survivin and P53 Expression in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy
Authors: A. Gasowska Bodnar, L. Bodnar, M. Jerzak, G. Wcisło, M. Cichowicz, A. Da˛bek, W. Kozłowski, C. Szczylik, W. Baranowski
Journal: Annals of Oncology (2012)
Mediators in psychological and psychoeducational interventions for the prevention of depression and anxiety. A systematic review
Authors: Patricia Moreno-Peral, Juan Ángel Bellón, Marcus J.H. Huibers, José M. Mestre, Luís Joaquín García-López, Svenja Taubner, Alberto Rodríguez-Morejón, Felix Bolinski, Célia M.D. Sales, Sonia Conejo-Cerón
Journal: Clinical Psychology Review (2020)
Oncological Outcomes of Metastatic Renal Cell Carcinoma (MRCC) with Molecular-Targeted Therapy in Asahikawa Medical University Hospital
Authors: J. Hori, K. Kitahara, K. Hashidume, N. Wada, G. Tamaki, M. Kita, T. Motoya, T. Iwata, S. Matsumoto, H. Kakizaki
Journal: Annals of Oncology (2012)
Immunogenicity and Safety of the Prame Cancer Immunotherapeutic in Metastatic Melanoma: Phase I/II Dose Escalation Study
Authors: R. Gutzmer, L. Rivoltini, E. Levchenko, A. Testori, J. Utikal, P.A. Ascierto, B. Salaun, N. Vanhoutte, M. Gillet, V. Brichard
Journal: Annals of Oncology (2012)
Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (MCRC): Patient Characteristics, Safety and Effectiveness in the Erebus Cohort
Authors: D. Smith, M. Rouyer, E. Mitry, E. Francois, A. Monnereau, A. Sa-Cunha, J. Jove, P. Noize, N. Moore, A. Fourrier-Réglat
Journal: Annals of Oncology (2012)
Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization
Authors: Noa Dagan, Eldad Elnekave, Noam Barda, Orna Bregman-Amitai, Amir Bar, Mila Orlovsky, Eitan Bachmat, Ran D. Balicer
Journal: Nature Medicine (2020)
Safety and Pharmacokinetic Evaluation of Palonosetron Given on Day 1 and 3 for Patients Who are to Receive a High or Moderate Risk of Chemotherapy-Induced Nausea and Vomiting (CINV)
Authors: Y. Ikari, Y. Nakasima, E. Sato, M. Masaki, H. Katsuya, A. Shirahashi, T. Tanaka, K. Ishitsuka, Y. Takamatsu, K. Tamura
Journal: Annals of Oncology (2012)
Skin-Test Infiltrating Lymphocytes Predict Clinical Outcome of Dendritic Cell Based Vaccination in Metastatic Melanoma
Authors: K. Bol, E. Aarntzen, W.R. Gerritsen, G. Schreibelt, J. Jacobs, W.J. Lesterhuis, M. van Rossum, C.J.A. Punt, C. Figdor, J. De Vries
Journal: Annals of Oncology (2012)
Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts
Authors: Alexandre Belot, Gillian I Rice, Sulliman Ommar Omarjee, Quentin Rouchon, Eve M D Smith, Marion Moreews, Maud Tusseau, Cécile Frachette, Raphael Bournhonesque, Nicole Thielens, Christine Gaboriaud, Isabelle Rouvet, Emilie Chopin, Akihiro Hoshino, Sylvain Latour, Bruno Ranchin, Rolando Cimaz, Paula Romagnani, Christophe Malcus, Nicole Fabien, Marie-Nathalie Sarda, Behrouz Kassai, Jean-Christophe Lega, Stéphane Decramer, Pauline Abou-Jaoude, Ian N Bruce, Thomas Simonet, Claire Bardel, Pierre Antoine Rollat-Farnier, Sebastien Viel, Héloise Reumaux, James O'Sullivan, Thierry Walzer, Anne-Laure Mathieu, Gaelle Marenne, Thomas Ludwig, Emmanuelle Genin, Jamie Ellingford, Brigitte Bader-Meunier, Tracy A Briggs, Michael W Beresford, Yanick J Crow, Dominique Campion, Jean-Francois Dartigues, Jean-François Deleuze, Emmanuelle Genin, Jean-Charles Lambert, Richard Redon, Emma Allain-Launay, Brigitte Bader-Meunier, Alexandre Belot, Kenza Bouayed, Stephane Burtey, Aurélia Carbasse, Stéphane Decramer, Véronique Despert, Olivier Fain, Michel Fischbach, Hugues Flodrops, Caroline Galeotti, Eric Hachulla, Yves Hatchuel, Jean-Francois Kleinmann, Isabelle Kone-Paut, Aurélia Lanteri, Irène Lemelle, Hélène Maillard, François Maurier, Ulrich Meinzer, Isabelle Melki, Sandrine Morell-Dubois, Anne Pagnier, Maryam Piram, Bruno Ranchin, Héloise Reumaux, Charlotte Samaille, Jean Sibilia, Olivia Weill, Eslam Al-Abadi, Kate Armon, Kathryn Bailey, Michael Beresford, Mary Brennan, Coziana Ciurtin, Janet Gardner-Medwin, Kirsty Haslam, Daniel Hawley, Alice Leahy, Valentina Leone, Devesh Mewar, Rob Moots, Clarissa Pilkington, Athimalaipet Ramanan, Satyapal Rangaraj, Annie Ratcliffe, Philip Riley, Ethan Sen, Arani Sridhar, Nick Wilkinson, Fiona Wood
Journal: The Lancet Rheumatology (2020)
Non-Randomized Comparison between Irinotecan–Mitomycin C and Irinotecan alone in Patients with Advanced Gastric Cancer Refractory to Fluoropyrimidine and Platinum
Authors: A. Ueda, A. Hosokawa, K. Ogawa, A. Kamuro, H. Yoshita, N. Nakada, T. Andou, S. Kajiura, Y. Tsukioka, T. Kobayashi, N. Horikawa, Y. Nishida, N. Hirai, M. Terada, T. Sugiyama
Journal: Annals of Oncology (2012)
Functional Electron Microscopy, “Flash and Freeze,” of Identified Cortical Synapses in Acute Brain Slices
Authors: Carolina Borges-Merjane, Olena Kim, Peter Jonas
Journal: Neuron (2020)

How structural and functional properties of synapses relate to each other is a fundamental question in neuroscience. Electrophysiology has elucidated mechanisms of synaptic transmission, and electron microscopy (EM) has provided insight into morphological properties of synapses. Here we describe an enhanced method for functional EM (“flash and freeze”), combining optogenetic stimulation with high-pressure freezing. We demonstrate that the improved method can be applied to intact networks in acute brain slices and organotypic slice cultures from mice. As a proof of concept, we probed vesicle pool changes during synaptic transmission at the hippocampal mossy fiber-CA3 pyramidal neuron synapse. Our findings show overlap of the docked vesicle pool and the functionally defined readily releasable pool and provide evidence of fast endocytosis at this synapse. Functional EM with acute slices and slice cultures has the potential to reveal the structural and functional mechanisms of transmission in intact, genetically perturbed, and disease-affected synapses.
P-0047 Substituting 5-Fluorouracil for Xeloda and Cisplatin for Carboplatin may be an Acceptable Alternative in Advanced Gastric Cancer: an Ongoing Retrospective Study
Authors: Dimosthenis Zylis, Alketa Gika, Kyriaki Florou, Lambros Markos, Anna Ntokou, Despina Geka, Elias Stavrinides, Alexandros Ardavanis
Journal: Annals of Oncology (2012)
Indicators Associated With Job Morale Among Physicians and Dentists in Low-Income and Middle-Income Countries
Authors: Alina Sabitova, Rose McGranahan, Francesco Altamore, Nikolina Jovanovic, Emma Windle, Stefan Priebe
Journal: JAMA Network Open (2020)

<h3>Importance</h3> Improving health care in low- and middle-income countries (LMICs) requires a workforce with positive job morale. However, the level of job morale in this population remains unclear. <h3>Objective</h3> To analyze studies measuring the job morale of physicians and dentists working in LMICs, using levels of job burnout, job satisfaction, and job motivation as indicators of job morale. <h3>Data Sources</h3> A comprehensive search of Scopus, PubMed, PsycINFO, EMBASE, Web of Science, and the Cochrane Library, from database inception to October 30, 2018, and gray literature was performed. <h3>Study Selection</h3> Studies were eligible if at least 50% of the sample were qualified physicians and/or dentists working in public health care settings in LMICs. Three indicators of job morale in this population were used: job burnout, job satisfaction, and job motivation. Of 12 324 records reviewed, 79 studies were included in the systematic review and 59 were eligible for the meta-analysis. <h3>Data Extraction And Synthesis</h3> Data were extracted independently by several investigators in accordance with the Meta-analyses of Observational Studies in Epidemiology (MOOSE) reporting guidelines. Random-effects meta-analyses, planned subgroup analyses, and metaregression were performed. The Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies was used to assess bias. <h3>Main Outcomes and Measures</h3> Levels of job burnout, job satisfaction, and job motivation as indicators of job morale. <h3>Results</h3> Overall, 12 324 records were identified. Of them, 80 records, representing 79 studies and involving 45 714 participants across 37 LMICs, met the inclusion criteria for the review; however, only 3 were from low-income countries. In 21 studies with 9092 participants working mainly in middle-income countries, 32% (95% CI, 27%-38%;<i>I</i><sup>2</sup> = 95.32%;<i>P</i> &lt; .001) reported job burnout, and in 20 studies with 14 113 participants, 60% (95% CI, 53%-67%;<i>I</i><sup>2</sup> = 98.21%;<i>P</i> &lt; .001) were satisfied with their job overall. Sufficient data were not available for a meta-analysis of job motivation. <h3>Conclusions and Relevance</h3> The findings suggest that, among physicians and dentists working mainly in middle-income countries, more than half reported having positive job morale. Positive job morale among physicians and dentists may help with recruitment and retention and thus support programs for improving health care in LMICs.
Trust and acceptance of a virtual psychiatric interview between embodied conversational agents and outpatients
Authors: Pierre Philip, Lucile Dupuy, Marc Auriacombe, Fushia Serre, Etienne de Sevin, Alain Sauteraud, Jean-Arthur Micoulaud-Franchi
Journal: npj Digital Medicine (2020)

Virtual agents have demonstrated their ability to conduct clinical interviews. However, the factors influencing patients' engagement with these agents have not yet been assessed. The objective of this study is to assess in outpatients the trust and acceptance of virtual agents performing medical interviews and to explore their influence on outpatients' engagement. In all, 318 outpatients were enroled. The agent was perceived as trustworthy and well accepted by the patients, confirming the good engagement of patients in the interaction. Older and less-educated patients accepted the virtual medical agent (VMA) more than younger and well-educated ones. Credibility of the agent appeared to main dimension, enabling engaged and non-engaged outpatients to be classified. Our results show a high rate of engagement with the virtual agent that was mainly related to high trust and acceptance of the agent. These results open new paths for the future use of VMAs in medicine.
Controversial red meat study adds correction over undisclosed industry funding
Authors: Owen Dyer
Journal: BMJ (2020)

A dietary guideline published in the Annals of Internal Medicine that contradicted years of public health advice by finding no significant benefit to individuals’ health in reducing red meat consumption has been corrected after the journal’s editor was notified of undisclosed industry funding received by the lead author.12

The recommendations, published last October, drew criticism3 because the lead author, Bradley Johnston, had authored a 2016 guideline, also published in Annals ,4 that questioned the benefits of limiting sugar intake. That study was funded by the International Life Sciences Institute, a body founded by a former Coca-Cola executive and viewed in some quarters as an industry group.5 The sugar study also had its disclosures corrected after publication, when the journal learnt that the institute had reviewed the manuscript, contrary to the authors’ initial declarations.

Johnston and the Annals ’ editor in chief, Christine Laine, argued that there was no obligation to report the institute’s …
Medical Image Analysis Using AM-FM Models and Methods
Authors: Kyriacos P. Constantinou, Ioannis P. Constantinou, Constantinos S. Pattichis, Marios S. Pattichis
Journal: IEEE Reviews in Biomedical Engineering (2020)

Medical image analysis methods require the use of effective representations for differentiating between lesions, diseased regions, and normal structure. Amplitude Modulation-Frequency Modulation (AM-FM) models provide effective representations through physically meaningful descriptors of complex non-stationary structures that can differentiate between the different lesions and normal structure. Based on AM-FM models, medical images are decomposed into AM-FM components where the instantaneous frequency provides a descriptor of local texture, the instantaneous amplitude captures slowly-varying brightness variations, while the instantaneous phase provides for a powerful descriptor of location, generalizing the traditionally important role of phase in the Fourier Analysis of images. Over the years, AM-FM representations have been used in a wide variety of medical image analysis applications based on a vastly reduced number of features that can be easily learned by simple classifiers. The paper provides an overview of AM-FM models and methods, followed by applications in medical image analysis. We also provide a summary of emerging trends and future directions.
Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography for Distinguishing between the Histologic Types of Early Stage Thymic Epithelial Tumors
Authors: T. Eguchi, K. Yoshida, K. Miura, H. Agatsuma, T. Sakaizawa, G. Saito, M. Hashizume, M. Toishi, T. Shiina, T. Koizumi
Journal: Annals of Oncology (2012)
External Quality Assessment for ALK Immunohistochemistry Testing in Lung Adenocarcinoma Within the European Thoracic Oncology Platform Lungscape Project
Authors: E. Thunnissen, K. Kerr, L. Bubendorf, D. Nonaka, F.H. Blackhall, R. Kammler, E.J. Speel, J. De Jong, M. Martorell, R.A. Stahel
Journal: Annals of Oncology (2012)
Antigen Presenting Cell (APC) Activation in Sipuleucel-T: Is Activation Increased in Earlier Prostate Cancer Disease States?
Authors: E.J. Small, J.D. Wesley, D.I. Quinn, C. Higano, D. Lin, H. Haynes, F. Stewart, J.B. Trager, N. Sheikh
Journal: Annals of Oncology (2012)